Moreover, a heightened proinflammatory state (as shown by increased C-reactive protein levels) is associated with treatment resistance in depression [74], which again emphasizes the importance of further research into anti-inflammatory treatments as a promising approach to improving treatments for depressed patients, particularly those who are resistant to currently available options. Here, CRP is linked to depressive symptom measurement.